Evidence map›Paper›PMID 28091564›Full record

ArticleScientific reports2017

Mitotic catastrophe is a putative mechanism underlying the weak correlation between sensitivity to carbon ions and cisplatin.

Daijiro Kobayashi, Takahiro Oike, Atsushi Shibata, Atsuko Niimi, Yoshiki Kubota, Makoto Sakai, Napapat Amornwhichet, Yuya Yoshimoto, Yoshihiko Hagiwara, Yuka Kimura and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. High-LET charged particles: radiobiology and application for new approaches in radiotherapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Frontiers in oncology · 2023
    Article
  10. Basic and translational research on carbon-ion radiobiology.American journal of cancer research · 2023
    Review
  11. Mutation Analysis of Radioresistant Early-Stage Cervical Cancer.International journal of molecular sciences · 2021
    Article
  12. Cancers · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Daijiro KobayashiDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Takahiro OikeDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Atsushi ShibataAdvanced Scientific Research Leaders Development Unit, Gunma University, Maebashi, Gunma, Japan.
Atsuko NiimiResearch Program for Heavy Ion Therapy, Division of Integrated Oncology Research, Gunma University Initiative for Advanced Research, Maebashi, Gunma, Japan.
Yoshiki KubotaGunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan.
Makoto SakaiGunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan.
Napapat AmornwhichetDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Yuya YoshimotoDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Yoshihiko HagiwaraAdvanced Scientific Research Leaders Development Unit, Gunma University, Maebashi, Gunma, Japan.
Yuka KimuraDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Yuka HirotaDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Hiro SatoDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Mayu IsonoGunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan.
Yukari YoshidaGunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan.
Takashi KohnoDivision of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
Tatsuya OhnoGunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan.
Takashi NakanoDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Gunma University · JPGunma University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In cancer therapy today, carbon ion radiotherapy is used mainly as monotherapy, whereas cisplatin is used concomitantly with X-ray radiotherapy. The effectiveness of concomitant carbon ions and cisplatin is unclear. To obtain the information on the mechanisms potentially shared between carbon ions or X-rays and cisplatin, we assessed the correlation of sensitivity to the single treatments. In 20 human cancer cell lines, sensitivity to X-rays strongly correlated with sensitivity to cisplatin, indicating the presence of potentially shared target mechanisms. Interestingly, the correlation of sensitivity to carbon ions and cisplatin was much weaker than that of sensitivity to X-rays and cisplatin, indicating the presence of potentially different target mechanisms between carbon ions and cisplatin. Assessment of clonogenic cell death by 4',6-diamidino-2-phenylindole dihydrochloride staining showed that mitotic catastrophe was more efficiently induced by carbon ions than by the same physical dose of X-rays, while apoptosis and senescence were not. These data indicate that the correlation of sensitivity to carbon ions and cisplatin is weaker than that of sensitivity to X-rays and cisplatin, which are helpful as biological basis to understand the potentially shared mechanism among these treatments. Further investigation is mandatory to elucidate the clinical efficacy of carbon ions and cisplatin combination.

Indexed as

Heavy Ion RadiotherapyApoptosisCell Line, TumorCisplatinClone CellsHumansMitosisX-RaysCisplatin

Identifiers

PMID28091564
PMCPMC5238371
OpenAlexW2572474721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.